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the prescribing physician’s response. The pharmacists evaluated
the clinical signiﬁcance of the interventions based on their own
clinical judgments. Analyses were performed using descriptive
statistics. RESULTS: A total of 504 interventions were docu-
mented over the 5-month study period. On average each inter-
vention took 15  14 (median, 10) minutes, ranging from 1
minute to 3 hours. The most common interventions performed
were on drug regimen change (n = 237; 47%), drug choice
(n = 128; 25%) and drug information issues (n = 106; 21%).
Dose change (n = 153; 30%) and patient education (n = 54;
11%) were the most frequent interventions performed in the
drug regimen change and drug information categories, respec-
tively. The most common indications for which interventions
were made were infectious (n = 100; 20%) and respiratory
(n = 77; 15%) diseases. Efﬁcacy was improved and toxicity
avoided in 38% (n = 193) and 28% (n = 140) of the interven-
tions, respectively. Potential fatalities or end-organ damage was
avoided in 1.6% (n = 8) of the cases while interventions of major
signiﬁcance was recorded in 43% (n = 215) of the interventions.
CONCLUSIONS: The data show that clinical pharmacists play
an important role in drug safety and efﬁcacy to optimize phar-
maceutical care as part of the multi-disciplinary team approach
in the hospital.
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OBJECTIVES: To evaluate the operation of the Afternoon Out-
patients Clinics (AOC) at the University General Hospital of
Larissa. The operation of AOC is a relatively new institution in
the country, introduced in 2001 by the 2889 NHS reform law.
METHODS: Descriptive and comparative analysis of data from
2002 of the AOC introduction up to 2006 is done. Data emanate
from the 5th Region Health Authority. Clinical and economic
indicators have been used for the evaluation based on medical
specialties, diagnostic and professional categories, operational
activities and ﬁnancial inputs and outputs. RESULTS: A progres-
sive increase in AOC visits has been estimated, reaching 82% of
total hospital outpatient visits with surgery accepting the bigger
volume of visits. Their income presents a 12.6% mean annual
increase while expenses reached 17.9% respectively. Financial
resources of surgical cases increased 63% and pathological 25%
over the period 2002–2006, with a 27% income increase of
gynaecological AOC 21% of orthopaedics and 7% of ophthal-
mologic. Social funds do not reimburse AOC visits and patients’
out of pocket payments are the main sources of the AOC
funding. CONCLUSIONS: The operation of the AOC is encour-
aging, since it motivates health professionals to increase their
income, the hospital to exploit its full potential, offers patients
access to quality health care and covers unmet needs. The fact
that the operation of the AOC is based on patients’ direct pay-
ments remains a contradiction with the full coverage of the Greek
population for the provision of outpatient and impatient care in
the public sector. The lack of contracting negotiations between
the social insurance funds and the regional or hospital authorities
remains a problem for which the state owes to make policy
decisions, since the prices that are overwhelmed are almost com-
petitive to the private sector and overload disproportionately the
lower incomes.
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OBJECTIVES: To register the opinions of the employees as con-
cerned the supply chain management, which has been adopted
from hospitals. METHODS: Data were collected via a question-
naire and were processed by using the logistic regression method.
A total of 250 people were asked, all employees of health care
industry. RESULTS: Only 6.5% of the employees knows the cost
of the materials they use and 82.2% of them state that if they
were aware of the cost of the materials, they would certainly use
them more wisely. Also, 55.1% of the survey participants were
dissatisﬁed with the supply chain procedure and 55.6% would
rather each clinic or laboratory managed its supplying by itself.
Finally, 59.2% of the employees believes that there are no incen-
tives and control as far as hospital’s supply chain management.
CONCLUSIONS: There is a pressing need for the Greek hospi-
tals to re-organize their supply chain management in order to
reduce cost and offer quality health care.
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OBJECTIVES: To identify and analyse differences in the ﬁnanc-
ing of drugs between Autonomous Regions (AR) in Spain.
METHODS: A structured literature review on the IME, SciELO,
Doyma, Medline, Cochrane, national and AR ofﬁcial bulletins,
relevant Spanish scientiﬁc associations and AR health web pages,
and general and specialised press, up to June 15, 2007.RESULTS:
Nine AR legislative documents were identiﬁed, one national
working document, two press releases, one AR instruction, four
scientiﬁc articles and twoministerial documents. The most impor-
tant ﬁndings are as follows. Navarre and Andalusia ﬁnance some
drugs excluded from national public funding by the Royal Decree
1663/1998. Navarre, La Rioja, Extremadura and Madrid ﬁnance
smoking cessation products for the general population whereas
Cantabria and Catalonia only to some population groups. The
postcoital pill is ﬁnanced in Andalusia, Cantabria, Catalonia,
Canary Islands, Aragon, Asturias and Galicia. Erectile dysfunc-
tion drugs for patients with medullar damage are ﬁnanced in
Valencia, Murcia, Balearic Islands and Castile la Mancha. Differ-
ences have been detected in the ﬁnancing level (reduced co-
payment or free of charge) of several drugs for speciﬁc population
groups. Castile Leon has a reduced co-payment in antiviral and
antifungal drugs for cancer patients. Extremadura ﬁnances the
totality of the drugs to chronic patients younger than 14 years old
and families with more than 3 children, and Valencia ﬁnance total
treatment costs of tuberculosis drugs.CONCLUSIONS:There are
differences in the ﬁnancing of various pharmaceutical products
with low intrinsic value, life-style drugs and preventive drugs.
These inequalities may be perceived as a reason of inequity or may
reﬂect the intention to redistribute health care resources among
AR’s preferences. It is necessary to evaluate the preferences of the
population and the way these differences affect their health status.
PHP45
THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE
Nixon F
Heron Evidence Development Ltd, Letchworth Garden City, UK
OBJECTIVES: Orphan medicinal product legislation was
adopted in Europe in 2000 with the aim of promoting the devel-
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opment of treatments for rare diseases. This has resulted in 515
EU designations for orphan medicinal products in June 2008.
Many orphan drugs (ODs) receive market authorisation,
however there are problems regarding access and reimbursement.
This study compares OD policies and examines the reimburse-
ment of ODs across Europe. METHODS: Policies on ODs in
European countries for which sufﬁcient detail had been published
were examined. HTA websites were searched for assessments on
ODs and data extracted on the recommendations. RESULTS: In
some countries, including Sweden and The Netherlands, ODs
may be approved for reimbursement with minimal documenta-
tion of cost-effectiveness. However, many countries, including
England and Scotland do not have speciﬁc polices for the
appraisal and reimbursement of ODs. This results in many
patients across Europe who do not see any beneﬁt from the
orphan product legislation. By April 2008, 45 drugs with desig-
nated OD status had been given European marketing authorisa-
tion in 42 different indications. Thirty-seven submissions had
been assessed by the SMC by June 2008 according to the stan-
dard appraisal procedures, with 4 accepted for use, 13 accepted
for restricted use and 20 not recommended in NHS Scotland
(11%, 35% and 54%, respectively). This contrasts with previ-
ously published data on recommendations from the SMC; 30%
approved, 35% restricted, 36% not recommended (Karia et al.
2008). Furthermore, by June 2008, NICE had only assessed 2
OD indications, with 4 ODs currently undergoing assessment
and 3 proposed as topics for assessment. CONCLUSIONS: The
granting of market authorisation by the EMEA does not always
lead to reimbursement of a drug; patient access to ODs varies
across different European countries.
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OBJECTIVES: The quantity of research generated is increasing
yearly. It is of interest to determine the types of research being
published to assess the content of the current knowledge base.
Research can be categorized as randomized controlled trials
(RCTs), observational studies (OS), systematic reviews (SR), or
economic studies (ES). Our aim was to determine the proportion
of research being conducted in these categories and to assess the
relative proportions of each across time. METHODS: A citation
search was conducted in Medline on 18 June 2008. Search ﬁlters
for RCTs, OS, SR, and ES were implemented to provide an
estimate of research conducted in these categories for the years
1950–2007. The prevalence of each type of research was calcu-
lated and changes over time were analysed using logistic regres-
sions. RESULTS: The total probable citations retrieved were:
740 599 for RCTs, 1 217 246 for OS, 1 287 915 for SR, and
325 625 for ES. The proportion of research conducted for each
of these overall was 20.7%, 34.1%, 36.1%, and 9.1%, respec-
tively. From 1977 to 2007 there was a 12-fold increase in prob-
able RCTs, a 15-fold increase in both probable OS and SR, and
a 9-fold increase in probable ES. Logistic regression analysis
showed a signiﬁcant association between category and time
(p < 0.0005). CONCLUSIONS: The majority of research being
conducted appears to be focused on OS or reviews of the litera-
ture. In contrast, probable RCTs and ES, which are arguably the
most useful and rigorous forms of research, together consist of
less than one third of the research being conducted. Furthermore,
the increase in this research during the previous 30 years is lower
than that of OS and SR. It is possible that the focus on SR reﬂects
the growing recognition of the importance of this literature
searching technique.
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OBJECTIVES: We aim to investigate uncontrolled associations
between HRQOL and health services utilization among primary
care patients in mainland China. METHODS: A retrospective
cross-sectional design was carried out among patients consulting
in primary care in mainland China. Health services utilization
was measured by the number of monthly outpatient consultation
and the annual hospitalization rate. HRQOL was measured by
either electronic or paper version of the Chinese SF-36. The
clustered model was adapted to calculate the independent con-
tributions from scores of the SF-36 subscales. A total of 733 valid
subjects were eventually recruited for this study. RESULTS: The
score of MH has a negative association with the number of
monthly outpatient consultation and its independent contribu-
tion explained within the clustered model was 7.0%, whereas
both the score of GH and PF have negative associations with the
annual hospitalization rate and the independent contributions
from GH and PF was a total of 22.2%. CONCLUSIONS: In
summary, this was the ﬁrst study verifying that scores of the
SF-36 subscales have negative associations with outpatient and
inpatient consultation among primary care patients in mainland
China.
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OBJECTIVES: As Medicare Part D results in de facto centraliza-
tion of buying power in the US, we hypothesized that NICE
HTA’s would increasingly inﬂuence the US market. The primary
objective is to determine whether major ﬁndings of Health Tech-
nology Appraisals (HTAs) by the National Institute for Clinical
Excellence (NICE; UK) impacted US trends in prescription
volume, retail price and out-of-pocket costs of statins and of six
therapeutic classes deemed medically necessary for Medicare
beneﬁciaries. As a point of reference, we sought to investigate the
same market factors in relation to the index date of Medicare
Part D introduction. METHODS: The two most prescribed
statins (atorvastatin, simvastatin), anticonvulsants (clonazepam,
gabapentin), antidepressants (escitalopram, ﬂuoxetine), oral
antineoplastics (capecitabine, imatinib), antipsychotics (quetiap-
ine, risperidone), immunosuppressants (azathioprine, mycophe-
nolate), and antiretrovirals (emtricitabine/tenofovir, ritonavir)
were selected based on total prescriptions (TRx). TRx, average
retail price (ARP) and average out-of-pocket costs (OPC) per
prescription were collected quarterly for 2005–2008. For six
related HTAs conducted by NICE and the implementation of
Medicare Part D, TRx, ARP and OPC were analyzed for the
same number of quarters before and after the index event.
Parameters were collected using Verispan’s VONA and VOPA
databases. Statistical analyses were performed using one-way
ANOVA. RESULTS: From 2005 to 2008, 7 of the 14 drugs
analyzed were directly or indirectly covered by a NICE HTA.
Two HTAs were correlated with a signiﬁcant increase in TRx,
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